We help our clients in the healthcare industries
build value for their products using four essential steps
PHMR Market Access Alerts
Your personal watchdog on the fast-moving pharmaceutical world
Our market access alerts are hand-picked items of breaking industry news. You can become a subscriber for free and receive these alerts direct to your inbox.
Our industry specific knowledge of the field allows us sort through the mass of worldwide news and go straight to the items which will affect you.
Our latest alerts direct to your inbox.
Just enter your email address below and we'll make sure you never miss out on a market access alert again.
Alternatively you can unsubscribe here.
- 27 Mar 2015 UK cancer survival rates, latest NICE guidance and two reports show NICE slows market access for cancer drugs
- 20 Mar 2015 3 medicines remain in the Cancer Drug Fund and Australian Pharma calls to fast track oncology drugs
- 13 Mar 2015 Skin cancer drug first in early access scheme, SMC issues latest recommendations and NHS selects 29 sites for new models of care
- 6 Mar 2015 AMNOG approach could provide European model for transparency, Rare Disease Day and NICE issues new guidance
- 27 Feb 2015 NICE QALY may be too high, Manchester to take control of health budget and two Remicade biosimilars launched in the UK
- 20 Feb 2015 UK spending on health doubled in past 20 years, EU medicines project comes to a close and Remicade biosimilar launched
- 13 Feb 2015 SMC latest recommendations, Italy’s off label law sparks Industry to file complaint and latest cancer drugs in development
- 5 Feb 2015 No further price cuts for non-PPRS drugs and one in two will develop cancer in the UK
- 30 Jan 2015 How innovative are drugs launched in the UK? EMA approves antibiotics and 2014 Euro Health Consumer Index
- 23 Jan 2015 Europe to boost international cooperation on generics under pilot scheme and head of Cancer Drug Fund regrets its formation